← All stocks

Cartesian Therapeutics, Inc.

RNAC No buying or selling
CIK 0001453687 #3561 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

17 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
SPRINGER TIMOTHY A
Director
9,302,798
$63.44M
+11.4%
Kalayoglu Murat
10% owner
5,824,838
$39.72M
+64.4%
Hoge Elizabeth
10% owner
5,313,261
$36.23M
+75.0%
Brunn Carsten
President and CEO
323,530
$2.21M
+97.4%
Davis Blaine
Chief Financial Officer
121,220
$826.68K
+50.0%
English Emily
Chief Operations Officer
94,226
$642.59K
+415.7%
Jewell Christopher M
Chief Scientific Officer
62,490
$426.16K
+140.9%
Kurtoglu Metin
Chief Technology Officer
62,258
$424.58K
+22.0%
Miljkovic Milos
Chief Medical Officer
58,820
$401.13K
+221.9%
BARABE TIMOTHY C
Director
56,966
$388.49K
+161.7%
Singer Michael
Director
49,578
$338.11K
−58.6%
COX CARRIE SMITH
Director
15,629
$106.59K
+20.0%
ZENNER PATRICK J
Director
12,974
$88.48K
+66.9%
DeSilva Nishan M
Director
11,366
$77.51K
+84.3%
Malik Kemal
Director
11,133
$75.92K
+87.6%
Seymour June Ann
Chief Accounting Officer
6,500
$44.33K
Bot Adrian Ion
Director
5,800
$39.55K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 21 Dec 2016